New News information at World Pharmaceutical Frontiers New and updated information from News listed on www.worldpharmaceuticals.net http://www.worldpharmaceuticals.net/ en-us http://www.worldpharmaceuticals.net/ New News information at World Pharmaceutical Frontiers http://www.worldpharmaceuticals.net/content/images/logo_big.gif Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene http://www.worldpharmaceuticals.net/news/newsanalytical-service-leaders-in-biopharmaceutical-and-gene-therapy-development-unify-operations-and-re-brand-as-protagene-13122-9400700 http://www.worldpharmaceuticals.net/news/newsanalytical-service-leaders-in-biopharmaceutical-and-gene-therapy-development-unify-operations-and-re-brand-as-protagene-13122-9400700 by <br/> <br/> Heilbronn & Heidelberg, Germany and Boston, USA – January 12, 2022: Following the announced merger in July 2021, Protagen Protein Services GmbH, BioAnalytix, Inc., and GeneWerk GmbH today announced their unified operations and re-brand as ProtaGene, a world-leading CRO partner for the biopharmaceutical and cell & gene therapy industries. Thu, 13 Jan 2022 10:08:00 GMT Wheeler Bio Announces $14M Seed Round To Expand Access To Portable CMC™ http://www.worldpharmaceuticals.net/news/newswheeler-bio-announces-14m-seed-round-to-expand-access-to-portable-cmc-9366215 http://www.worldpharmaceuticals.net/news/newswheeler-bio-announces-14m-seed-round-to-expand-access-to-portable-cmc-9366215 by <br/> <br/> OKLAHOMA CITY, OK, January 4, 2022 – (BUSINESS WIRE) – Wheeler Bio, a biomanufacturing company built to accelerate the translation of therapeutic innovation into clinical impact, announced today the closing of a $14M Seed financing round. The round was co-led by Echo Investment Capital and Alloy Therapeutics, with participation from Floating Point and Presbyterian Health Foundation. Wed, 05 Jan 2022 13:45:00 GMT Watertown, MA (USA) – November 15, 2021 http://www.worldpharmaceuticals.net/news/newswatertown-ma-usa-november-15-2021-9251313 http://www.worldpharmaceuticals.net/news/newswatertown-ma-usa-november-15-2021-9251313 by <br/> <br/> Arranta Bio Announces Completion of Sale of Florida Site and Progress on $150M Investment Plan to Expand Development and Commercial Manufacturing Services Tue, 16 Nov 2021 14:16:00 GMT TriRx Hosted State and Community Leaders to Celebrate Acquisition of Shawnee, Kansas Facility http://www.worldpharmaceuticals.net/news/newstrirx-hosted-state-and-community-leaders-to-celebrate-acquisition-of-shawnee-kansas-facility-8991017 http://www.worldpharmaceuticals.net/news/newstrirx-hosted-state-and-community-leaders-to-celebrate-acquisition-of-shawnee-kansas-facility-8991017 by <br/> <br/> NORWALK, Conn., Aug. 11, 2021/ -- TriRx Pharmaceutical Services, LLC, a leading international CDMO, hosted Kansas Lt. Governor David Toland, Shawnee Mayor Michelle Distler, State Senator Mike Thompson, Congresswoman Jo Ella Hoye, Congresswoman Cindy Neighbor, other Shawnee city leaders, representatives from The University of Kansas, Kansas State University, and key customers at a ribbon-cutting ceremony, Tuesday, August 10. Thu, 12 Aug 2021 10:30:00 GMT TriRx Completes Acquisition of Elanco Animal Health Facility in Shawnee, Kansas http://www.worldpharmaceuticals.net/news/newstrirx-completes-acquisition-of-elanco-animal-health-facility-in-shawnee-kansas-8960336 http://www.worldpharmaceuticals.net/news/newstrirx-completes-acquisition-of-elanco-animal-health-facility-in-shawnee-kansas-8960336 by <br/> <br/> Norwalk, CT (August 2, 2021): TriRx Pharmaceutical Services, LLC, a leading international CDMO, announced today that it has finalized and closed on an agreement with Elanco Animal Health Incorporated (NYSE:ELAN) to acquire the ownership and operations of its manufacturing site in Shawnee, Kansas. Elanco is a global animal health leader dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets. The two companies also entered into a long-term supply agreement for this site. Tue, 03 Aug 2021 11:09:00 GMT DFE Pharma expands co-processed portfolio with launch of Pharmacel® sMCC 90 http://www.worldpharmaceuticals.net/news/newsdfe-pharma-expands-co-processed-portfolio-with-launch-of-pharmacel-smcc-90-8906901 http://www.worldpharmaceuticals.net/news/newsdfe-pharma-expands-co-processed-portfolio-with-launch-of-pharmacel-smcc-90-8906901 by <br/> <br/> Pharmacel® sMCC 90 excipient improves tablet compression, aiding higher production speed, enabling rapid formulation development Mon, 19 Jul 2021 07:45:00 GMT DFE Pharma Launches Ultimate Excipient Solution for Biopharma http://www.worldpharmaceuticals.net/news/newsdfe-pharma-launches-ultimate-excipient-solution-for-biopharma-8906898 http://www.worldpharmaceuticals.net/news/newsdfe-pharma-launches-ultimate-excipient-solution-for-biopharma-8906898 by <br/> <br/> BioHale® Sucrose, part of the new and expanded BioHale® portfolio line, offers exceptional purity stabilization for biologics. Mon, 19 Jul 2021 07:43:00 GMT Webinar: galenIQ™ - Ask the Expert http://www.worldpharmaceuticals.net/news/newswebinar-galeniq---ask-the-expert-8523469 http://www.worldpharmaceuticals.net/news/newswebinar-galeniq---ask-the-expert-8523469 by <br/> <br/> galenIQ™ is a soluble filler and binder that can be used to meet many of the current trends and challenges of the pharmaceutical and nutraceutical industries. Tue, 16 Feb 2021 13:15:00 GMT Chemspec Europe 2021 postponed. The 35th International Exhibition for Fine and Speciality Chemicals will now take place as live and digital hybrid event from 29 to 30 September 2021 http://www.worldpharmaceuticals.net/news/newschemspec-europe-2021-postponed-the-35th-international-exhibition-for-fine-and-speciality-chemicals-will-now-take-place-as-live-and-digital-hybrid-event-from-29-to-30-september-2021-8523244 http://www.worldpharmaceuticals.net/news/newschemspec-europe-2021-postponed-the-35th-international-exhibition-for-fine-and-speciality-chemicals-will-now-take-place-as-live-and-digital-hybrid-event-from-29-to-30-september-2021-8523244 by <br/> <br/> Mack-Brooks Exhibitions has today announced the postponement of Chemspec Europe 2021, which was scheduled to take place at Messe Frankfurt in Germany from 19 to 20 May 2021. Instead, the International Exhibition for Fine and Speciality Chemicals will run as an enhanced show from 29 to 30 September 2021, combining the physical event with an online platform. This decision was taken in light of the ongoing Covid-19 pandemic. Tue, 16 Feb 2021 12:03:00 GMT SGS INCREASES ITS CAPACITY FOR HUMAN CHALLENGE STUDIES http://www.worldpharmaceuticals.net/news/newssgs-increases-its-capacity-for-human-challenge-studies-8372068 http://www.worldpharmaceuticals.net/news/newssgs-increases-its-capacity-for-human-challenge-studies-8372068 by <br/> <br/> <img height='60px' width='60px' src= ' /Uploads/NewsArticle/8372068/thumbnail.jpg'/></a>SGS will move its Clinical Pharmacology Unit (CPU) to a new location in 2021, increasing its capacity to conduct Human Challenge studies. Fri, 20 Nov 2020 13:16:00 GMT